Highlander Capital Management’s Idexx Laboratories IDXX Stock Holding History

Highlander Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$62K	–	600
2021 Q3	$62K	Hold	100	–	–	0.03%	254
2021 Q2	$63K	Hold	100	–	–	0.03%	264
2021 Q1	$49K	Hold	100	–	–	0.03%	301
2020 Q4	$50K	Hold	100	–	–	0.03%	288
2020 Q3	$39K	Buy	+100	New	+$37K	0.02%	316
2016 Q3	–	Sell	-500	Closed	-$46K	–	779
2016 Q2	$46K	Hold	500	–	–	0.04%	369
2016 Q1	$39K	Hold	500	–	–	0.04%	402
2015 Q4	$36K	Buy	500 +300	+150%	+$21.4K	0.03%	415
2015 Q3	$14K	Buy	+200	New	+$14.3K	0.01%	600
2014 Q3	–	Sell	-600	Closed	-$40.1K	–	864
2014 Q2	$40.1K	Hold	600	–	–	0.04%	400
2014 Q1	$36.4K	Buy	+600	New	+$35.7K	0.03%	406

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Highlander Capital Management's IDXX Position: Q4 2021 in Review

Highlander Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 100 shares — an estimated $62K sold.

Highlander Capital Management first reported a position in IDXX in Q1 2014 and held it in 11 quarters. The position peaked at $63K in Q2 2021. 1,106 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

Highlander Capital Management reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
Highlander Capital Management sold 100 Idexx Laboratories shares in Q4 2021, an estimated $62K.
Highlander Capital Management first reported a position in Idexx Laboratories in Q1 2014 and held it in 11 quarters.
Highlander Capital Management's Idexx Laboratories position peaked at $63K in Q2 2021.
1,106 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Highlander Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.